Review article · 2019

Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers

Kei Xian Tan, Sharadwata Pan, Jaison Jeevanandam, Michael K. Danquah

International Journal of Pharmaceutics, 558, 413–425 · Published 18 January 2019 · DOI 10.1016/j.ijpharm.2019.01.023

View at the publisherCite this paper

In brief

“Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers” is a 2019 review article by Kei Xian Tan and 3 co-authors, published in International Journal of Pharmaceutics. OpenAlex counts 41 citations as of 21 November 2026, which puts it in the top 6% of works published in 2019 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
41
Most cited in
2021 (9)
Field-weighted impact
0.36
References
169
Authors
4

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tan, K. X., Pan, S., Jeevanandam, J., & Danquah, M. K. (2019). Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers. International Journal of Pharmaceutics, 558, 413–425. https://doi.org/10.1016/j.ijpharm.2019.01.023

MLA 9

Tan, Kei Xian, et al. “Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers.” International Journal of Pharmaceutics, vol. 558, 2019, pp. 413–425. https://doi.org/10.1016/j.ijpharm.2019.01.023.

Chicago

Tan, Kei Xian, Sharadwata Pan, Jaison Jeevanandam, and Michael K. Danquah. 2019. “Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers.” International Journal of Pharmaceutics 558: 413–425. https://doi.org/10.1016/j.ijpharm.2019.01.023.

Harvard

Tan, K. X. et al. (2019) ‘Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers’, International Journal of Pharmaceutics, 558, pp. 413–425. doi:10.1016/j.ijpharm.2019.01.023.

IEEE

K. X. Tan, S. Pan, J. Jeevanandam, and M. K. Danquah, “Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers,” International Journal of Pharmaceutics, vol. 558, pp. 413–425, 2019, doi: 10.1016/j.ijpharm.2019.01.023.

BibTeX

@article{tan2019cardiovascular,
  title     = {{Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers}},
  author    = {Tan, Kei Xian and Pan, Sharadwata and Jeevanandam, Jaison and Danquah, Michael K.},
  journal   = {International Journal of Pharmaceutics},
  year      = {2019},
  volume    = {558},
  pages     = {413--425},
  doi       = {10.1016/j.ijpharm.2019.01.023},
  url       = {https://doi.org/10.1016/j.ijpharm.2019.01.023}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201944
202088
202199
202233
202333
202466
202544
202644

Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • targeted drug delivery
  • nanomedicine
  • nanoparticles
  • aptamers
  • cardiovascular disease
  • myocardial infarction
  • ischemic heart disease
  • nanoparticle drug delivery

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Tan, K. X., Pan, S., Jeevanandam, J., & Danquah, M. K. (2019). Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers. International Journal of Pharmaceutics, 558, 413–425. https://doi.org/10.1016/j.ijpharm.2019.01.023

How many times has this paper been cited?

41 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Kei Xian Tan, Sharadwata Pan, Jaison Jeevanandam, Michael K. Danquah.

What is the DOI of this paper?

10.1016/j.ijpharm.2019.01.023, permanently at https://doi.org/10.1016/j.ijpharm.2019.01.023. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.